21 (60.0) 10.0 (2.5–25.0) Adverse gastrointestinal reactions 24 (15) 14 (58.3) 50 (19–84) 18 (75.0) 12 (50.0) 15.0 (7.5–30.0)
No takes yet. Share an insight, caveat, or question.
Due et al. (2012) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: